Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

An overview of Synchron's BCI system and how it allows users with motor impairment to control their digital devices. Credit: Synchron / Business Wire. · Medical Device Network · Synchron / Business ...

ALS patient Philip O'Keefe was implanted with Synchron's Stentrode brain-computer interface in 2020 as part of the first clinical trial of the device. In December 2021, he became the first person to ...

Australian startup Synchron, backed by Bill Gates and Jeff Bezos, looks set to beat Elon Musk's Neuralink to market with a safe, reliable brain-computer interface that any hospital can quickly install ...

Synchron’s Stentrode system is implanted in the brain’s motor cortex in a minimally invasive procedure via the jugular vein. Once there, it transmits brain signals to a connected computer to help ...

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Synchron, a brain computer ...

California Start-up Synchron recently published its study and findings in the success of the "Stentrode" Brain chips implanted in the blood vessels of paralyzed and disabled patients to help them ...

US-based Synchron has secured $200m in a Series D funding round to drive the commercial rollout of its Stentrode brain-computer interface (BCI) platform and aid in the creation of next-generation ...

Neurovascular bioelectronics medicine company Synchron Inc. has received good news in the form of a breakthrough device designation for its Stentrode. The U.S. FDA granted the designation for the ...

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. Stentrode is the only implantable brain-computer interface that does not require open ...